Janellen Smith, MD
Enriched profileHealth Sciences Professor, Dermatology · University of California, Irvine
Janellen Smith is Health Sciences Professor, Dermatology at University of California, Irvine. OpenAlex indexes 69 publications with 517 citations (h-index 10); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 4 Nov 2026
Overview
Updated 4 Nov 2026
Janellen Smith, MD, is Health Sciences Professor, Dermatology at University of California, Irvine (UC Irvine School of Medicine). The public record shows 69 publications with 517 citations (h-index 10), centered on Dermatology and Skin Diseases, Cutaneous Melanoma Detection and Management, Drug-Induced Adverse Reactions. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies.
- Most recent indexed publication: 2025 · JMIR dermatology
- Top research focus: Dermatology and Skin Diseases
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 4 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 2 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 10.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 4 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 4 Nov 2026
2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:
- Janssen Global Services, LLCProgram year20253 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Janssen Global Services, LLCProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
29%Corticosteroid14.7%Triamcinolone Acetonide100%Part D≥96 patientsInterleukin-4 Receptor alpha Antagonist8.4%Dupixent Pen84%Dupixent Syringe16%Part D<11 patients+ 5 more classes in this area
Anti-infectives
28.2%Azole Antifungal16%Ketoconazole100%Part D≥84 patientsLincosamide Antibacterial4.5%Clindamycin Phosphate100%Part D≥19 patients+ 3 more classes in this area
Sensory organs
18.3%Corticosteroid18.3%Clobetasol Propionate57%Hydrocortisone43%Part D≥59 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 4 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evaluating Artificial Intelligence Models in Dermatology: Comparative Analysis.
JMIR dermatology
Article2025 - Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis.
The Australasian journal of dermatology
Letter2022
Most-cited works
by citation count (OpenAlex)- 01The banned sunscreen ingredients and their impact on human health: a systematic reviewReview118 citations2020
- 02Selection of Tumorigenic Melanoma Cells Using ALDHArticle105 citations2010
- 03Dupilumab-Induced Follicular ConjunctivitisArticle44 citations2018
- 04Diffuse cutaneous mastocytosis: Case report and literature reviewArticle32 citations2018
- 05Cutaneous reactions with enfortumab vedotin: A case series and review of the literatureArticle31 citations2021
Network
Updated 4 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 4 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/janellen-smith-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
profiles.icts.uci.edu/janellen.smith
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.icts.uci.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 4 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucihealth.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucihealth.org ↗
- Fellowship: Washington University
Molecular Biology and Dermatology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucihealth.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ucihealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Susan O’Brien, MD
University of California, Irvine
Steven Potkin, MD
University of California, Irvine
Stefan Ciurea, MD
University of California, Irvine
Farshid Dayyani, MD
University of California, Irvine
Jedd Wolchok, MD
Weill Cornell Medicine
Frank Hodi, MD
Dana-Farber Cancer Institute
Keith Flaherty, MD
Massachusetts General Hospital
Omid Hamid, MD
The Angeles Clinic and Research Institute